This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2002, 1% of adults were taking gabapentinoids (gabapentin and or pregabalin). 2006 Transcript Eric: Welcome to the GeriPal Podcast. Summary Transcript Summary Gabapentin is the 10th most prescribed drug in the United States and use is increasing. By 2015 that number increased to 4% of US adults. Annals of IM. This is Eric Widera.
AAHPM (American Academy of Hospice and Palliative)
MAY 16, 2024
I served in Mother Teresa’s Home for the Dying in Kolkata, India on various occasions (2002-2006) which inspired my eventual path toward palliative care. Brenner, MD MPA has been recognized as one of the exceptional individuals chosen as a 2024 AAHPM Emerging Leader in Hospice and Palliative Care.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
238 
Let's personalize your content